1 |
Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma[J]. Nat Rev Cancer, 2013, 13(2): 123-135.
|
2 |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297.
|
3 |
Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact[J]. J Clin Oncol, 2009, 27(34): 5848-5856.
|
4 |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. J CA Cancer J Clin, 2011, 61(2): 69-90.
|
5 |
Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future[J]. Semin Cancer Biol, 2011, 21(1): 59-69.
|
6 |
Yao M, Yao DF, Bian YZ, et al. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(2): 171-179.
|
7 |
Lin S, Hoffmann K, Schemmer P. Treatment of hepatocellular carcinoma: a systematic review[J]. Liver Cancer, 2012, 1(3-4): 144-158.
|
8 |
Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma[J]. Oncogene, 2010, 29(36): 4989-5005.
|
9 |
Jin WB, Wu FL, Kong D, et al. HBV-encoded microRNA candidate and its target[J]. Comput Biol Chem, 2007, 31(2): 124-126.
|
10 |
Sullivan CS, Grundhoff AT, Tevethia S, et al. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells[J]. Nature, 2005, 435(7042): 682-686.
|
11 |
Liu Y, Zhao JJ, Wang CM, et al. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line[J]. Chin Med J(Engl), 2009, 122(1): 10-14.
|
12 |
Zhang GL, Li YX, Zheng SQ, et al. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210[J]. Antiviral Res, 2010, 88(2): 169-175.
|
13 |
Wu FL, Jin WB, Li JH, et al. Targets for human encoded microRNAs in HBV genes[J]. Virus Genes, 2011, 42(2): 157-161.
|
14 |
Qiu L, Fan H, Jin W, et al. miR-122-induced downregulation of HO-1 negatively affects miR-122-mediated suppression of HBV[J]. Biochem Biophys Res Commun, 2010, 398(4): 771-777.
|
15 |
Liu WH, Yeh SH, Chen PJ. Role of microRNAs in hepatitis B virus replication and pathogenesis[J]. Biochim Biophys Acta, 2011, 1809(11-12): 678-685.
|
16 |
Wolf K, Friedl P. Molecular mechanisms of cancer cell invasion and plasticity[J]. Br J Dermatol, 2006, 154 (Suppl 1): 11-15.
|
17 |
Hurst DR, Welch DR. Metastasis suppressor genes at the interface between the environment and tumor cell growth[J]. Int Rev Cell Mol Biol, 2011, 286: 107-180.
|
18 |
Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities[J]. Nat Rev Cancer, 2010, 10(1): 9-22.
|
19 |
Roycik MD, Fang X, Sang QX. A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates[J]. Curr Pharm Des, 2009, 15(12): 1295-1308.
|
20 |
Lopez-Camarillo C, Marchat LA, Arechaga-Ocampo E, et al. MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis[J]. Int J Mol Sci, 2012, 13(2): 1347-1379.
|
21 |
Zender L, Villanueva A, Tovar V, et al. Cancer gene discovery in hepatocellular carcinoma[J]. J Hepatol, 2010, 52(6): 921-929.
|
22 |
Zhang ZZ, Liu X, Wang DQ, et al. Hepatitis B virus and hepatocellular carcinoma at the miRNA level[J]. World J Gastroenterol, 2011, 17(28): 3353-3358.
|
23 |
Wang W, Zhao LJ, Tan YX, et al. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma[J]. World J Gastroenterol, 2012, 18(38): 5442-5453.
|
24 |
Li J, Shi W, Gao Y, et al. Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma[J]. Clin Lab, 2013, 59(9-10): 1009-1015.
|
25 |
Liu AM, Zhang C, Burchard J, et al. Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma[J]. OMICS, 2011, 15(3): 187-191.
|
26 |
Fan CG, Wang CM, Tian C, et al. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3[J]. Oncol Rep, 2011, 26(5): 1281-1286.
|
27 |
Li C, Wang Y, Wang S, et al. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion[J]. J Virol, 2013, 87(4): 2193-2205.
|
28 |
Fu Y, Wei X, Tang C, et al. Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma[J]. Oncol Lett, 2013, 6(6): 1811-1815.
|
29 |
Zhu HT, Dong QZ, Sheng YY, et al. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection[J]. PLoS One, 2012, 7(12): e52393.
|
30 |
Zhang X, Liu S, Hu T, et al. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression[J]. Hepatology, 2009, 50(2): 490-499.
|
31 |
Huang J, Wang Y, Guo Y, et al. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1[J]. Hepatology, 2010, 52(1): 60-70.
|
32 |
Wang Y, Lu Y, Toh ST, et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3[J]. J Hepatol, 2010, 53(1): 57-66.
|
33 |
Wu G, Yu F, Xiao Z, et al. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro[J]. Br J Cancer, 2011, 105(1): 146-153.
|
34 |
Kong G, Zhang J, Zhang S, et al. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model[J]. PLoS One, 2011, 6(5): e19518.
|
35 |
Wei X, Xiang T, Ren G, et al. miR-101 is down-regulated by the methyltransferase 3A[J]. Cell Signal, 2013, 25(2): 439-446.
|
36 |
Xu X, Fan Z, Kang L, et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis[J]. J Clin Invest, 2013, 123(2): 630-645.
|
37 |
Xu Y, Li L, Xiang X, et al. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis[J]. Gene, 2013, 527(2): 584-593.
|
38 |
Song FJ, Chen KX. Single-nucleotide polymorphisms among microRNA: big effects on cancer[J]. Chin J Cancer, 2011, 30(6): 381-391.
|
39 |
Qi P, Dou TH, Geng L, et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection[J]. Hum Immunol, 2010, 71(6): 621-626.
|
40 |
Kwak MS, Lee DH, Cho Y, et al. Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients[J]. PLoS One, 2012, 7(7): e41983.
|